DUBLIN - Medtronic plc today announced that the company has received U.S. Food and Drug Administration (FDA) approval for the CareLink SmartSync(TM) Device Manager. With the introduction of SmartSync, ...
Medtronic describes the new system as a next-generation replacement for its CareLink 2090 programmer, which had its internet update functionality disabled last year amid concerns of cyberattacks.
A system that allows physicians to manage Bluetooth-enabled pacemaker devices using an app on an Apple iPad has been approved by the FDA, medical technology maker Medtronic announced on May 2. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results